Stay updated with breaking news from James Stevermer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The U.S. Preventive Services Task Force released a recommendation this week calling on health care providers to prescribe all approved PrEP options for people at increased risk for HIV.
The new statement gave ‘A’ grades to all 3 FDA-approved PrEP drugs: Truvada, Descovy, and an injectable called Apretude.
Two new antiretrovirals have been approved by the US Food and Drug Administration since the US Preventive Services Task Force's last report, which now includes new options.
Preexposure prophylaxis should be prescribed to individuals at risk of acquiring HIV to prevent HIV, according to the USPSTF.
TUESDAY, Aug. 22, 2023 (HealthDay News) -- The U.S. Preventive Services Task Force (USPSTF) recommends prescription of preexposure prophylaxis (PrEP) with effective antiretroviral therapy for individuals at increased risk for HIV acquisition. This recommendation forms the basis of a final recommendation statement published in the Aug. 22/29 issue of the Journal of the American Medical